Literature DB >> 12580925

Radiotherapy in acromegaly: the argument against.

Ariel L Barkan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12580925     DOI： 10.1046/j.1365-2265.2003.01704.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  12 in total

Review 1.  Growth hormone and its disorders.

Authors:  J Ayuk; M C Sheppard
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

Review 2.  GH receptor antagonist: mechanism of action and clinical utility.

Authors:  Sowmya K Surya; Ariel L Barkan
Journal:  Rev Endocr Metab Disord       Date:  2005-01       Impact factor: 6.514

3.  Nelfinavir induces radiation sensitization in pituitary adenoma cells.

Authors:  Jing Zeng; Alfred P See; Khaled Aziz; Saravanan Thiyagarajan; Tarek Salih; Rajendra P Gajula; Michael Armour; Jillian Phallen; Stephanie Terezakis; Lawrence Kleinberg; Kristen Redmond; Russell K Hales; Roberto Salvatori; Alfredo Quinones-Hinojosa; Phuoc T Tran; Michael Lim
Journal:  Cancer Biol Ther       Date:  2011-10-01       Impact factor: 4.742

4.  Efficacy and safety of CyberKnife radiosurgery for acromegaly.

Authors:  Brian K Roberts; Daniel L Ouyang; Shivanand P Lad; Steven D Chang; Griffith R Harsh; John R Adler; Scott G Soltys; Iris C Gibbs; Lynn Remedios; Laurence Katznelson
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

Review 5.  Characteristics of acromegaly in Korea with a literature review.

Authors:  Jae Won Hong; Cheol Ryong Ku; Sun Ho Kim; Eun Jig Lee
Journal:  Endocrinol Metab (Seoul)       Date:  2013-09

Review 6.  Acromegaly.

Authors:  Massimo Scacchi; Francesco Cavagnini
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

Review 7.  Does acromegaly enhance mortality?

Authors:  John Ayuk; Michael C Sheppard
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

Review 8.  Pharmacological therapy for acromegaly: a critical review.

Authors:  Alex F Muller; Aart Jan Van Der Lely
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Management of type 2 diabetes mellitus associated with pituitary gigantism.

Authors:  Omar Ali; Swati Banerjee; Daniel F Kelly; Phillip D K Lee
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

Review 10.  Management of acromegaly in Latin America: expert panel recommendations.

Authors:  Ariel Barkan; Marcello D Bronstein; Oscar D Bruno; Alejandro Cob; Ana Laura Espinosa-de-los-Monteros; Monica R Gadelha; Gloria Garavito; Mirtha Guitelman; Ruth Mangupli; Moisés Mercado; Lesly Portocarrero; Michael Sheppard
Journal:  Pituitary       Date:  2010-06       Impact factor: 4.107
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.